Thalidomide therapy in adult patients with myelodysplastic syndrome: a north central cancer treatment group phase II trial.
Musto
Pellegrino
P
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D013792:Thalidomide